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Cannabinoid receptors (CB) are G-protein coupled
receptors involved in many physiological processes, like
learning, appetite, nociception and others. Two subtypes
(termed CB1 and CB2) are involved in slightly different
processes [1]. Thus, it is important to gain more insight
into the the cannabinoid receptor system and the poten-
tial effects of cannabinoid therapeutics.
By combining [2] 3D-QSAR, pharmacophore model-
ing, comparative modeling and molecular docking we
could identify features responsible for receptor subtype
specificity.
Various pharmacophore models were derived from in-
house libraries and data available in the literature. 3D
structures of both receptor subtypes were created
employing comparative modeling methods. The models
were subjected to molecular simulations in solvated
lipid bilayers to sample different receptor conformations.
The models were used for molecular docking studies
with small compound libraries. Employing the data
obtained in the pharmacophore/3D-QSAR studies as
additional constraints delivered valuable information on
affinity and selectivity of the compounds towards CB1
and CB2. The results from this synergistic modeling
approach could improve our understanding of the pro-
tein–ligand interactions involved.
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